Antidyslipidemia Pharmacotherapy in Chronic Kidney Disease: A Systematic Review and Bayesian Network Meta-Analysis.
Guangzhi LiaoXiangpeng WangYiming LiXuefeng ChenKe HuangLin BaiYuyang YeYong PengPublished in: Pharmaceutics (2022)
In nondialysis CKD patients, statin-based therapies could significantly and safely reduce all-cause death and major composite cardiovascular events despite the presence of arteriosclerotic cardiovascular disease and LDL-c levels. Aggressive medication regimens, PS and HS, appeared to be more effective, especially in patients with established CAD.
Keyphrases
- cardiovascular events
- cardiovascular disease
- coronary artery disease
- end stage renal disease
- systematic review
- chronic kidney disease
- ejection fraction
- type diabetes
- peritoneal dialysis
- prognostic factors
- emergency department
- randomized controlled trial
- meta analyses
- metabolic syndrome
- cardiovascular risk factors
- adverse drug
- patient reported
- electronic health record